Recently, the first-ever OpenHarmony Technical Forum in Europe successfully concluded in Rotterdam, the Netherlands. Centered on the theme of “OpenHarmony Technology Innovation and Ecosystem Practice,”

US FDA Approves Expanded Indication for Novartis Leqvio (inclisiran) to Include Treatment of Adults with High LDL-C and Who Are At Increased Risk of Heart Disease
EAST HANOVER, N.J., July 10, 2023 /PRNewswire/ — Novartis announced today that
Continue reading »